Home/Filings/4/0000950170-25-033649
4//SEC Filing

HENSON HEIDI 4

Accession 0000950170-25-033649

CIK 0000728387other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:25 PM ET

Size

5.8 KB

Accession

0000950170-25-033649

Insider Transaction Report

Form 4
Period: 2025-03-03
HENSON HEIDI
Director
Transactions
  • Award

    Stock option (right to buy)

    2025-03-03+50,00050,000 total
    Exercise: $2.46Exp: 2035-03-03Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025.
  • [F2]Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date.

Documents

1 file

Issuer

Perspective Therapeutics, Inc.

CIK 0000728387

Entity typeother

Related Parties

1
  • filerCIK 0001283301

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:25 PM ET
Size
5.8 KB